Drug maker AbbVie reports 'excellent' third quarter
October 29, 2021 at 10:28 AM EDT
Increased sales of its Humira, Skyrizi and Rinvoq immunology drugs contributed to the good quarter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|